0.4502
price down icon3.60%   -0.0168
after-market 시간 외 거래: .45 -0.0002 -0.04%
loading

Lyell Immunopharma Inc (LYEL) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
76.92%
0.003
0.013 0.025 0.027 0.065
Operating Expenses
6.62%
55.58
59.52 59.06 65.93 62.62
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
6.62%
55.58
59.52 59.06 65.93 62.62
Operating Income/Loss
6.61%
-55.58
-59.51 -59.04 -65.91 -62.56
Nonoperating Income/Loss
177.41%
-5.092
6.578 8.186 2.015 -4.403
Income/Loss From Continuing Operations Before Tax
76.92%
0.003
0.013 0.025 0.027 0.065
Income/Loss From Continuing Operations After Tax
14.62%
-60.67
-52.93 -50.85 -63.89 -66.96
Net Income/Loss
14.62%
-60.67
-52.93 -50.85 -63.89 -66.96
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
41,856%
254.25
0.606 251.32 250.20 249.59
Diluted Average Shares
41,856%
254.25
0.606 251.32 250.20 249.59
Basic Earnings Per Share
20.00%
-0.24
-0.20 -0.20 -0.26 -0.27
Diluted Earnings Per Share
20.00%
-0.24
-0.20 -0.20 -0.26 -0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
자본화:     |  볼륨(24시간):